Verywell Health on MSN
More Price Cuts Are Coming for Diabetes Drugs. Here's What to Expect in 2026
Fact checked by Jennifer Klump Key Takeaways Insulin costs have declined over the past two years, and additional price cuts ...
Medications for type 2 diabetes address different aspects of blood sugar management and are tailored to individual health needs. Navigating type 2 diabetes treatment options can be complex, but ...
The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...
Is diabetes reversible? Here, endocrinologists explain the answer, including which types of diabetes can go into "remission" ...
An early trial suggests that a drug commonly used for rheumatoid arthritis could reduce type 1 diabetics' reliance on insulin, but questions remain. When you purchase through links on our site, we may ...
Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...
In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This approach could change how type 1 diabetes is treated, moving beyond just ...
HOUSTON — The American Diabetes Association (ADA) said it's concerned about the impact of potential shortages of certain types of insulin. Across the country, people are reporting having trouble ...
Type 2 diabetes patients on GLP-1 treatments, such as Ozempic, have a lower risk of 10 obesity-related cancers compared to those on insulin and other drugs, according to a new study. GLP-1 treatments ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results